RevSpring Acquires TrustCommerce
On February 20, RevSpring reported that it acquired TrustCommerce. The seller was Waud Capital Partners, who initially purchased the company in 2017. FT Partners served as the exclusive strategic and financial advisor to TrustCommerce. Financial terms of the deal were not disclosed. TrustCommerce is a leading financial technology company trusted by large health systems, hospitals and ambulatory practices. The TrustCommerce integrated payment platform can reduce friction and facilitate secure, compliant patient payments. It connects patients with core electronic health records and practice management software. RevSpring provides analytics-driven communications and payment... Read More »
Istios Health Expands into the Nephrology Field
On February 19, Istios Health reported that it was expanding its services into the nephrology field with the acquisition of three practices: Central Mass Nephrology, Teredesai McCann & Associates and Coordinated Kidney Care Group. Terms were not disclosed. Central Mass Nephrology is a nephrology practice based out of nine clinic locations in Massachusetts and one in Connecticut. It also operates nine dialysis locations across Massachusetts. According to the website, the practice is run by a team of four physicians. Teredesai McCann & Associates is a nephrology practice with seven locations across Pennsylvania. According to its website, there are 11 physicians on... Read More »
Swiss Rockets AG Acquires Complete Genomics
Swiss Rockets AG, based in Basel, Switzerland, announced on February 23 that it entered into a definitive agreement to acquire Complete Genomics, Inc. Complete Genomics is a leader in whole human genomic sequencing, which is used by research centers to conduct medical research that, in the future, is expected to be used to improve both prevention and treatment of disease. Since its founding in 2005, the company has been at the forefront of high-throughput, cost-effective sequencing innovation, supporting more than 10,900 scientific publications worldwide. Swiss Rockets is a portfolio of biotechnology companies. Its portfolio includes radioligand therapies, small molecules... Read More »
Specialty1 Partners Announces Second Acquisition of 2025
Triumphant Transition Partners announced that it acted as an advisor to Dr. Francisco Perez as he joined Specialty1 Partners. The practice of Dr. Francisco Perez is based in Edinburg, Texas. Dr. Perez, an oral and maxillofacial surgeon, is the only physician on staff. Specialty1 Partners, backed by private equity firm VSS Capital Partners, is the parent company of dental-surgical partnerships Endo1 Partners, Perio1 Partners and OS1 Partners. It maintains and scales practices to optimize performance and turn goals into reality. Specialty1 has established partnerships with more than 225 practices and has a network of more than 350 specialists across 28 states. The financial... Read More »
Gilead Inks $7.8 Billion Deal to Purchase Arcellx
On February 23, Gilead Sciences, Inc. announced that it has entered into a definitive agreement to acquire Arcellx, Inc. Under the terms of the agreement, Arcellx shareholders will receive $115 per share in cash at closing plus one contingent value right of $5 per share, representing an implied equity value of $7.8 billion payable at closing. Arcellx is a clinical-stage biotechnology company focused on delivering a new class of immunotherapies for patients with cancer and other incurable diseases. Arcellx’s lead pipeline candidate, anitocabtagene autoleucel (anito-cel), is currently in a Phase 2 pivotal trial for patients with relapsed or refractory multiple myeloma. According to its most... Read More »
Enhabit to be Acquired by Kinderhook Industries for $1.1 Billion
Enhabit, Inc. announced on February 23 that it has entered into a definitive agreement to be acquired by Kinderhook Industries, LLC, a middle market private equity firm. Kinderhook Industries is acquiring Enhabit in an all-cash transaction for a total enterprise value of approximately $1.1 billion. Enhabit is a leading national home health and hospice provider with headquarters in Dallas, Texas. Enhabit’s team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 249 home health locations and 117 hospice locations across 34 states. According to its most recent annual filing, Enhabit generated approximately $1.03 billion in... Read More »
Center for Social Dynamics Expands Footprint in Southwest With Acquisition
Center for Social Dynamics (CSD) announced that it is strengthening its footprint in the Southwest with its latest addition. The company is acquiring Behavior Change Institute (BCI) in Alamogordo, New Mexico. BCI is an autism services provider specializing in diagnostic evaluations, early intervention and evidence-based behavioral therapies. BCI has earned a reputation as one of New Mexico’s most trusted autism care providers, serving families across urban and rural communities and playing a pivotal role in reducing barriers to diagnosis and treatment. Founded in 2012, CSD is a provider of evidence-based autism and behavioral health services, built around a clinical curriculum... Read More »
Hims & Hers Announces Agreement to Acquire Eucalyptus
Hims & Hers Health, Inc., the leading health and wellness platform, announced on February 19 that it has entered into a definitive agreement to acquire Eucalyptus. As its U.S. business continues to grow, Hims & Hers will be positioned, upon closing of the acquisition, to expand into Australia and Japan and deepen its presence in the United Kingdom, Germany and Canada. Founded in 2019, Eucalyptus builds and operates a network of digital healthcare companies. The company has facilitated nearly two million consultations across Australia, the United Kingdom, Germany, Japan and Canada. Hims & Hers is a multi-specialty telehealth platform based in San Francisco, California. Hims... Read More »
Tactile Systems Technology Buys LymphaTech for $6.8 Million Upfront
Tactile Systems Technology, Inc. announced that it is acquiring LymphaTech for an upfront cash payment at closing of $6.8 million, plus potential additional consideration that is contingent upon the achievement of future milestones. Founded in 2014, LymphaTech is a privately held medical technology company pioneering a digital, three-dimensional full body measurement and monitoring platform designed specifically for lymphedema. Tactile Systems Technology is a medical technology company focused on developing medical devices for the treatment of underserved chronic diseases at home. The company develops and markets at-home therapies for people suffering from underserved, chronic conditions,... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
